Abstract C043: Addition of losartan to FOLFORINOX and chemoradiation downregulates pro-invasion and immunosuppression-associated genes in locally advanced pancreatic cancer
ContributorsBoucher, Yves; Posada, Jessica M.; Subudhi, Sonu; Rosario, Spencer R.; Gu, Liqun; Kumar, Ashwin S.; Kumra, Heena; Mino-Kenudson, Mari; Talele, Nilesh P.; Duda, Dan G.; Fukumura, Dai; Wo, Jennifer Y.; Clark, Jeffrey W.; Ryan, David P.; Castillo, Carlos Fernandez-Del; Hong, Theodore S.; Pittet, Mikaël; Jain, Rakesh K.
Presented atAACR Special Conference, Pancreatic cancer, Boston, MA, September 13-16, 2022, p. C043
Publication date2022-11-15
Abstract
NoteAbstract publié dans Cancer research, 2022, vol. 82, issue 22, Supplement ; preprint posté sur https://www.medrxiv.org/content/10.1101/2022.06.09.22275912v1
Citation (ISO format)
BOUCHER, Yves et al. Abstract C043: Addition of losartan to FOLFORINOX and chemoradiation downregulates pro-invasion and immunosuppression-associated genes in locally advanced pancreatic cancer. In: AACR Special Conference. Boston, MA. 2022. C043 p. doi: 10.1158/1538-7445.PANCA22-C043
Secondary files (1)
Summary
Identifiers
- PID : unige:166168
- DOI : 10.1158/1538-7445.PANCA22-C043